Prospector Partners LLC Has $7.37 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Prospector Partners LLC cut its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 59.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 272,475 shares of the medical instruments supplier’s stock after selling 402,495 shares during the period. Prospector Partners LLC’s holdings in DENTSPLY SIRONA were worth $7,373,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in XRAY. First Eagle Investment Management LLC increased its holdings in DENTSPLY SIRONA by 33.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after purchasing an additional 3,283,965 shares in the last quarter. Nuance Investments LLC grew its holdings in DENTSPLY SIRONA by 3.8% during the second quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock worth $271,019,000 after buying an additional 402,329 shares in the last quarter. FMR LLC grew its holdings in DENTSPLY SIRONA by 5.1% during the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock worth $245,076,000 after buying an additional 436,031 shares in the last quarter. Cooke & Bieler LP raised its position in DENTSPLY SIRONA by 16.2% in the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after buying an additional 1,046,105 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in DENTSPLY SIRONA by 42.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock valued at $110,118,000 after acquiring an additional 1,308,411 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 4.0 %

XRAY opened at $19.52 on Tuesday. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $37.60. The company’s 50-day moving average price is $23.25 and its two-hundred day moving average price is $25.05. The stock has a market cap of $3.88 billion, a price-to-earnings ratio of -9.43, a PEG ratio of 1.84 and a beta of 1.02. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $951.00 million for the quarter, compared to analysts’ expectations of $939.10 million. During the same quarter in the previous year, the firm posted $0.49 EPS. DENTSPLY SIRONA’s revenue was up .4% on a year-over-year basis. As a group, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on XRAY shares. Barrington Research reduced their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Tuesday, November 19th. Needham & Company LLC decreased their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Friday, October 25th. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Finally, Evercore ISI reduced their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $29.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.